000			01967 a2200529 4500
005			20250515172536.0
264		0	_c20090727
008			200907s 0 0 eng d
022			_a1471-2407
024	7		_a10.1186/1471-2407-9-160 _2doi
040			_aNLM _beng _cNLM
100	1		_aMärten, Angela
245	0	0	_aA randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2. _h[electronic resource]
260			_bBMC cancer _cMay 2009
300			_a160 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAdult
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aMale
650	0	4	_aPancreatic Neoplasms _xdrug therapy
650	0	4	_aProspective Studies
650	0	4	_aRecombinant Proteins
650	0	4	_aYoung Adult
700	1		_aSchmidt, Jan
700	1		_aOse, Jennifer
700	1		_aHarig, Sabine
700	1		_aAbel, Ulrich
700	1		_aMünter, Marc W
700	1		_aJäger, Dirk
700	1		_aFriess, Helmut
700	1		_aMayerle, Julia
700	1		_aAdler, Guido
700	1		_aSeufferlein, Thomas
700	1		_aGress, Thomas
700	1		_aSchmid, Roland
700	1		_aBüchler, Markus W
773	0		_tBMC cancer _gvol. 9 _gp. 160
856	4	0	_uhttps://doi.org/10.1186/1471-2407-9-160 _zAvailable from publisher's website
999			_c18895910 _d18895910